Episode Details

197 - Frontier AI as Foreign Policy, Medicare Expands Weight-Loss Drugs, and Health Systems Face the Outpatient Reckoning

Episode 197 Published 3 months, 3 weeks ago

Description

Vic and Marcus discuss slowing U.S. job growth, Meta's move into AI cloud infrastructure, record venture funding driven by AI, and what those trends mean for the technology sector. They examine Medicare coverage for weight loss drugs, proposed CMS changes affecting hospitals, Medicaid work requirement lawsuits, and the continued shift of care away from hospitals. They also cover major healthcare advances, including expanded gene therapy for children with sickle cell disease, AI-powered drug discovery partnerships, and the first FDA-approved Treg cell therapy. The episode concludes with the record-low U.S. death rate, stablecoin adoption, blockchain tokenization, and the growing AI competition between the U.S. and China.

Story Lineup

1 — In This Economy

3:47 - Story 1: U.S. labor market cools sharply: June jobs report shows only 57,000 positions added [WSJ]

7:14 - Story 2: Meta Is Planning a Cloud Business to Sell AI Computing Power [Bloomberg]

2 — VC Deal Review

10:30 - Story 1: Global startup investment surges to record $510B in H1 2026 as AI exits accelerate [Crunchbase News]

12:40 - Story 2: Beeline raises $126M Series A extension on heels of $300M launch, bolsters autoimmune pipeline [Fierce Biotech]

3 — Policy

14:15 - Story 1: Medicare begins covering GLP-1 weight-loss drugs for seniors at $50/month out-of-pocket starting July 1 [WSJ]

15:17 - Story 2: CMS targets 340B drug discount program and site-neutral pay in 2027 outpatient rule overhaul [Becker's Hospital Review]

21:20 - Story 3: Twenty-six states sue Trump administration over Medicaid work requirements rule implementation [Healthcare Dive]

4 — Health Payors